We’ll be pausing our presence on X. Come and follow us on @LinkedIn

RT @Neuroelectrics: Throwback to the exciting moment we announced our groundbreaking partnership with @neuronostics! 🤝. 🧠 Together, we're t….

RT @ncode_network: Call for Challenges for the 2025 N-CODE Study Group! Deadline 29th Jan.We invite stakeholders (industry, clinicians, cha….

RT @SMQB_UoB: 📢Companies, clinicians or charities with with an interest in the development of neurotechnology - a call to submit a challeng….

RT @neuro_manc: For neurologists wishing to develop EEG / epilepsy surgery / ICU cEEG skills. The post is ABN approved, the candidate will….

RT @EpilepsiaJourn: Key point: The study findings demonstrate the potential added value of computational biomarkers from #EEG for people wi….

Read our latest work where biomarker performance from clinically non-contributory EEG recordings in the context of epilepsy diagnostic decision support is presented. Congrats to all involved including @wessel_woldman @JT_Running and @haritsa1

Pleasure to attend the @Medilinksw awards last night, celebrating innovation across the South West. Proud sponsors of the Business-Academia Partnership award, congratulations to this year’s winners the Virtual Hippo Ltd. Thanks to @Medilinksw for a fantastic event. #Innovation.

RT @setsquared: 🧠 @Neuronostics is a multi-award-winning #medtech startup spun out of the @UniofExeter, on a mission to revolutionise how n….

We are #recruiting a research scientist. If you have a background in dynamical systems or computational neuroscience and are motivated by changing how neurological conditions such as #epilepsy are diagnosed and treated then get in touch!.

RT @SMQB_UoB: There's still time to register for our @PurpleDay Epilepsy Awareness Webinar! Tue 26th March 6.30-8pm GMT, featuring @Epileps….

Excited to share we've received @sbrihealthcare.funding for our #BioEP paediatric epilepsy study, in collaboration with @AACinnovation & @HealthInnovNe. Partnering with @haritsa1 , we aim to improve diagnosis speed and accuracy. Working towards #NetZero future with IEC.

Excited to be at the @SWinnovationexp Neuronostics is showcasing BioEP, our supporting tool to aid clinicians in #epilepsy diagnosis. Let's connect, share insights, and explore collaborations to improve epilepsy care. Reach out if you'd like to chat 🟣 #Innovation #MedTech

We're off to London as part of the final 10 in the @UKBAngels #Healthtech pitch finals. Looking forward to connecting this evening!"

Delighted that our co-founder @JT_Running takes this important role with @EpilepsyInst, acting as co-lead for Enabling Technologies. His expertise will advance understanding and treatment of #epilepsy, fostering a collaborative environment between academia, industry & healthcare.

CITADEL has gained REC approval, paving the way for evaluating how #BioEP can improve epilepsy diagnosis and care. Looking forward to working with CI @haritsa1 and @CornwallFT, alongside 7 other NHS sites. Now on NIHR portfolio, we're set for participant recruitment in March.

RT @EpilepsyInst: We are pleased to share that Rosemarie Pardington has taken up post as our new Chief Executive.​ As former Deputy CEO at….

Busy Thursday workshop at Neuronostics with new members of our team discussing our strategy for 2024 ➡️. A lot of exciting projects coming from Neuronostics this year. With more team members joining in the coming months, we may soon need to think about a bigger workshop space 🟣

RT @IlaeWeb: The #ILAEAcademy is pleased to announce the 6th ILAE School on Advanced EEG and Epilepsy in Dianalund will take place on 20-27….

We are thrilled to announce, we have regulated our Neuronostics Platform with the MHRA, delivering BioEP™ capabilities under UKCA. For more information get in touch or visit